AMRI TO KICK OFF FALL EVENTS SCHEDULE AT CHEMOUTSOURCING

GINA ROTHE | September 10, 2014

article image
AMRI will be jumping into its autumn schedule of events, starting with the 2014 ChemOutsourcing show, which is the largest U.S.-based API show attracting 700-800 chemists annually from the pharmaceutical, biotech, and chemical industries. From September 15-18, AMRI representatives are available to chat more about our offerings and expand on some of our recent business moves. Please make sure to contact us for a meeting or drop by our booth (#85) to find out more.

Spotlight

The Sequoia Project

The Sequoia Project is a non-profit 501c3 chartered to advance implementation of secure, interoperable nationwide health information exchange. The Sequoia Project supports health IT interoperability initiatives, most notably: the eHealth Exchange, a rapidly growing community of exchange partners who share information under a common trust framework and a common set of rules; and Carequality, a public-private collaborative effort to build consensus among existing data sharing networks regarding technical specifications and best practices, much like the telecommunications industry did for linking cell phone networks. For more information about The Sequoia Project, the eHealth Exchange and Carequality, visit www.sequoiaproject.org. Follow The Sequoia Project on Twitter: @SequoiaProject.

OTHER ARTICLES

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

What are the advantages of PCD Pharma Company?

Article | February 17, 2020

PCD Pharma stands for propaganda distribution. A PCD company gives brand name and support to its franchises. They also provide distribution rights and monopoly rights within a particular region. If a person wants to establish their business, it is a must for them to know the pros and cons of the business to make a sound decision. Needless to mention that PCD company has a lot to contribute in the medical filed. Worldwide in a medical field, A PCD Pharma Company is playing an essential and crucial role in the rapid growth. The pharma industry is progressing t a fast pace. The company uses the latest technologies for each brand which ensures the safety of products and accepts the responsibility of human health & life by providing better outcomes. To have a drug license number and company registration, the cost to establish the company is quite cost-effective that is15000-20000rs. So this gives people a brilliant opportunity to have their unit without digging a big hole in their bank balance. Indian produces exquisite quality products, which make pharma companies a considerable success.

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 20, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Article | March 11, 2020

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Read More

Spotlight

The Sequoia Project

The Sequoia Project is a non-profit 501c3 chartered to advance implementation of secure, interoperable nationwide health information exchange. The Sequoia Project supports health IT interoperability initiatives, most notably: the eHealth Exchange, a rapidly growing community of exchange partners who share information under a common trust framework and a common set of rules; and Carequality, a public-private collaborative effort to build consensus among existing data sharing networks regarding technical specifications and best practices, much like the telecommunications industry did for linking cell phone networks. For more information about The Sequoia Project, the eHealth Exchange and Carequality, visit www.sequoiaproject.org. Follow The Sequoia Project on Twitter: @SequoiaProject.

Events